A 51-year-old man with osteomyelitis developed acute renal failure and superior mesenteric venous (SMV)thrombosis after piperacillin (PIPC) treatment. Coagulation profile disclosed disseminated intravascular coagulation (DIC). The serum levels of IgE and eosinophil cationic protein showed significant increases, while a lymphocyte stimulation test with PIPC also demonstrated an extremely high index. These observations suggest that hypersensitivity to PIPC might play a role in the pathogenesis of acute renal failure and SMVthrombosis due to hypercoagulopathy. Withdrawal of PIPC and anticoagulation therapy resulted in clinical improvementand normalization of the affected laboratory data. This is the first report to describe PIPCinduced hypercoagulopathy.
Introduction
Piperacillin (PIPC) is a semi-synthetic penicillin with broadspectrum activity frequently used to treat respiratory disease, urinary tract infection, and sepsis. PIPC has been shown to be safe and well tolerated. Overall, most of its adverse effects were limited to allergic reactions and gastrointestinal disturbance (1) (2) (3) . There has been no previous report on DIC due to delayed hypersensitivity to PIPC. Wereport herein a case of PIPCinduced hypercoagulopathy associated with delayed hypersensitive reaction that was successfully treated with low-molecular weight heparin (LMWH).
Case Report
A 5 1-year-old man developed lumbar pain in June 1996. He was first admitted to a local hospital and diagnosed with osteomyelitis by bone biopsy. On July 30, intravenous injection of PIPC (2 g every 12 h) was started. Epidermal skin test with PIPC was negative. On day 25 of the treatment with PIPC, the patient developed high fever, abdominal pain, frequent vomiting, diarrhea, and a diffuse papuloerythematous rash on the arms, legs and trunk associated with severe pruritus. His urinary output decreased. He was transferred to our hospital for further investigation and treatment in late August 1996. His history did not reveal any noteable events such as allergy to antibiotics, diet or others. He had not received treatment for any preexisting medical illness and was not taking any medical prescription at presentation. On admission, his height was 167.0 cm, body weight 87.0 kg, body temperature 38.2°C, heart rate 78/min, and blood pressure 138/80 mmHg.He was conscious and well oriented, but he appeared restless. He had mild abdominal tenderness without rebound. There was generalized erythema and edemaof the limbs. Results of several laboratory tests on admission are summarized in Table 1 . Hematological parameters showed a marked shift to the left in the neutrophil series with eosinophilia. Biochemical tests revealed liver involvement, renal insufficiency, and a marked elevation of the LDHlevel. Elevation of the erythrocyte sedimentation rate and positive C-reactive protein were also observed. The serum levels of IgE and eosinophil cationic protein (ECP) also showed a significant increase. Coagulation studies ( Table 2) Anti-cardiolipin p2GP-l antibody Homocysteine (Fig. 1, arrow) .
A provisional diagnosis of hypercoagulopathy associated with delayed hypersensitive reaction due to piperacillin was made. The patient was examined by a dermatologist, who diagnosed a toxic reaction. The PIPC was discontinued after 30 days of therapy, and anticoagulant therapy using low-molecular weight heparin (LMWH) (MW=5,000) was administered intravenously (75 IU/kg/day). Because oliguria (less than 200 ml/day) continued despite the administration of diuretics, and the level of blood urea nitrogen and serum creatinine also be- cameelevated, hemodialysis was performed on the second hospital day. The urine volume gradually increased to 1,000 ml/day after the second hemodialysis. After 27 days of hospitalization, his renal function had improved with 9 courses of hemodialysis, and the levels of blood urea nitrogen and serum creatinine decreased to 20 mg/dl and 2 mg/dl, respectively. No renal biopsy was performed. The dermatological eruption gradually subsided within 10 days of the cessation of PIPC.
The symptoms improved dramatically, and the laboratory findings including coagulation profile returned to normal within one month (Fig. 2) . The patient was discharged in good condition without an anticoagulant.
Discussion
Allergic reactions are the chief adverse effects encountered with the use of penicillins. The reported mortality during penicillin anaphylaxis is approximately 10%. Large dosage or prolonged administration seems to be associated with a high frequency of untoward reactions (2) . Allergy to PIPC may be present in 1 to 2%of the population (3). Drug-induced fever (4) , various skin rashes (5-7), and acute tubulointerstitial nephritis (8) may occur with PIPC therapy. Nagay observed shortening of venous-blood coagulation time and formation of thrombi in the small circulation system in rabbits after penicillin injection (9) . He suggested that penicillin could increase the danger of thrombosis in cases wherethe equilibrium of the blood coagulation system is impaired. Somestudies have reported disseminated intravascular coagulation caused by penicillin hypersensitivity (10) (11) (12) , and Rye has reported hyperfibrinolytic coagulopathy with the development of a serum sickness-like illness (13) . However, to the author's knowledge there have not been any previous reports of hypercoagulation in association with delayed hypersensitivity to PIPC administration. The clinical features and laboratory findings that disclosed eosinophilia, the significantly elevated concentration of IgE and ECP in the serum, and the extremely high LSTindex for PIPC suggest that a double mechanism may be involved in the reaction, a type I and a cell-mediated type IV (14) that may act simultaneously, as suggested by de Week et al (15) . The present patient had not been exposed to any contrast agents, non-steroidal anti-inflammatory agents or other recognized hypercoagulable or nephrotoxic agents, except for PIPC. Although a re-challenge test of PIPC was not performed in order to avoid the clinical toxicity, the strongly positive result on LST as well as the clinical history indicated that the presumed causative agent for the hypercoagulopathy and acute renal insufficiency was PIPC. The pathogenesis of hypercoagulable conditions is multifactorial with mechanisms including release of proteins by activated lymphocytes and eosinophils, and co-morbid predisposing factors such as bed rest. In the patient reported here, the significantly high concentration of ECPin the serum suggested that he had had a hypersensitivity reaction, possibly to PIPC, and that activated eosinophils might play a role in the pathogenesis of hypercoagulopathy and acute renal failure (8, 16) . Weconsider it unlikely that any causes other than the administration of PIPCwere responsible for the present reactions. In general, hypercoagulopathy may be classified into a hereditary and an acquired state. The most commonhereditary type originates from a protein deficiency in one of the three liver-synthesized proteins: protein C, protein S, and antithrombin III. In the present case, the laboratory values were within the normal range on admission and one year after discharge, and the patient did not have prior thrombotic episodes nor contributory family history. Therefore, we considered this case to involve an acquired state. Mesenteric venous thrombosis is uncommon,accounting for 0.01% to 0.06% of surgical admissions and autopsies (17) . The factors makingpatients mostsusceptible to this condition are age, trauma, sluggish blood flow, and bacterial chemical toxins. In addition, visceral infections, previous abdominal surgery, and use of oral contraceptives are emphasized as contributory factors (18) . As SMVthrombosis has a high mortality rate, early management is recommended. CT has a high sensitivity and specificity for diagnosing splanchnic venous occlusion. With contrast-enhanced CT, SMVthrombosis is characterized by decreased intraluminal density, occasionally combined with a ringed enhancement of the vessel due to opacification of the vasa vasorum (19) . In the present case as well, contrast-enhanced CT was useful in diagnosing SMVthrombosis.
Wedescribed a patient with acute renal failure and SMV thrombosis associated with prolonged administration of PIPC. To our knowledge, this is the first report to describe PIPCinduced hypercoagulopathy. Physicians using prolonged courses of PIPC should note this finding.
